GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
620
c/compounding·posted 3 months ago by u/marit_mwangi

help me understand API source, I have read the wiki twice

Pricing Cold Box ×4

Long-ish post, sorry. tl;dr at the bottom.

I have been tracking telehealth against triglycerides for 31 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.

Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.

tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.

759 up / 139 down85% upvoted25 commentsid mitmis15 Apr 2026

25 comments

21 in this archive, depth 4

best — the order this archive was captured in

u/santiago_rasmussen86 points·3 months ago

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

replysharereportpermalink
u/prior_auth_painMOD52 points·3 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/marit_mwangiOP54 points·3 months ago

Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.

replysharereportpermalink
u/rt_shift_reggie42 points·3 months ago

state board rules differ, say which state

replysharereportpermalink
u/niels_roos-1 point·3 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/marit_mwangiOP1 point·3 months ago

The telehealth + compounding combo cost API source plus 8% markup. Not cheap but covered by insurance depending on state.

replysharereportpermalink
u/emeka_chowdhury100 points·3 months ago

The evidence standard in c/vendorvetting gets called too strict about once a month, and every time, the thread ends with the complainant agreeing.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/pavel_kravchenko52 points·3 months ago

state board rules differ, say which state

replysharereportpermalink
u/sofia_danquah23 points·3 months ago

the Poland situation is different from the US, different regulations

replysharereportpermalink
u/medutest_mel69 points·3 months ago

Are we talking 503A or 503B?

replysharereportpermalink
u/sofia_nascimento60 points·3 months ago

Did they tell you their API source or dodge the question?

replysharereportpermalink
u/cold_chromatogram3157 points·3 months ago

Half-life is about 168 hours, so steady state lands around week 12–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/medutest_mel13 points·3 months ago

503B compounding is different from 503A, different rules, different legality

replysharereportpermalink
u/discount_math_dm3 points·3 months ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/hassan_chowdhury2 points·3 months ago

telehealth costs 503B plus compounding markup, total varies

replysharereportpermalink
u/swirl_dont_shakereconstitution4 points·3 months ago

Strongly agree. API source transparency matters.

replysharereportpermalink
u/marit_mwangi3 points·3 months ago·edited

no pharmacy referral codes, naming is fine, recruiting is not

replysharereportpermalink
u/liver_enzyme_liz39 points·3 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/yusuf_kirchner12 points·3 months ago

This is correct. The shortage list does expire and the rules change.

replysharereportpermalink
u/rohan_steiner4 points·3 months ago

telehealth prescriber models exist, pricing differs by state

replysharereportpermalink
u/formulary_fighterappeals3 points·3 months ago

Yeah, 503A and 503B are different regulatory animals.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.